AU2008253040B2 - Probiotics in a pre- and/or post surgical environment - Google Patents

Probiotics in a pre- and/or post surgical environment Download PDF

Info

Publication number
AU2008253040B2
AU2008253040B2 AU2008253040A AU2008253040A AU2008253040B2 AU 2008253040 B2 AU2008253040 B2 AU 2008253040B2 AU 2008253040 A AU2008253040 A AU 2008253040A AU 2008253040 A AU2008253040 A AU 2008253040A AU 2008253040 B2 AU2008253040 B2 AU 2008253040B2
Authority
AU
Australia
Prior art keywords
composition
use according
probiotics
present
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2008253040A
Other languages
English (en)
Other versions
AU2008253040A1 (en
Inventor
Eduardo Schiffrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2008253040A1 publication Critical patent/AU2008253040A1/en
Application granted granted Critical
Publication of AU2008253040B2 publication Critical patent/AU2008253040B2/en
Assigned to Société des Produits Nestlé S.A. reassignment Société des Produits Nestlé S.A. Request for Assignment Assignors: NESTEC S.A.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2008253040A 2007-05-18 2008-05-14 Probiotics in a pre- and/or post surgical environment Active AU2008253040B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07108492.5A EP1992351B1 (en) 2007-05-18 2007-05-18 Lactobacillus johnsonii for prevention of postsurgical infection
EP07108492.5 2007-05-18
PCT/EP2008/055898 WO2008141989A1 (en) 2007-05-18 2008-05-14 Probiotics in a pre- and/or post surgical environment

Publications (2)

Publication Number Publication Date
AU2008253040A1 AU2008253040A1 (en) 2008-11-27
AU2008253040B2 true AU2008253040B2 (en) 2014-06-12

Family

ID=38476047

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008253040A Active AU2008253040B2 (en) 2007-05-18 2008-05-14 Probiotics in a pre- and/or post surgical environment

Country Status (15)

Country Link
US (2) US8529887B2 (https=)
EP (2) EP1992351B1 (https=)
JP (2) JP5497634B2 (https=)
CN (2) CN101678054A (https=)
AU (1) AU2008253040B2 (https=)
BR (1) BRPI0811180A2 (https=)
CA (1) CA2686976C (https=)
CL (1) CL2008001446A1 (https=)
DK (1) DK1992351T3 (https=)
ES (1) ES2578261T3 (https=)
MX (1) MX2009012255A (https=)
RU (1) RU2470652C2 (https=)
TW (1) TW200902040A (https=)
WO (1) WO2008141989A1 (https=)
ZA (1) ZA200909002B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
CA2724554A1 (en) * 2008-05-15 2009-11-19 Youdocs, Llc Methods and systems for improving human health using targeted probiotics
WO2010096550A2 (en) * 2009-02-18 2010-08-26 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
WO2010096564A2 (en) * 2009-02-19 2010-08-26 Probiohealth Llc Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits
EP2413849B1 (en) 2009-04-03 2014-07-02 Metamodix, Inc. Modular gastrointestinal prostheses
US9173760B2 (en) 2009-04-03 2015-11-03 Metamodix, Inc. Delivery devices and methods for gastrointestinal implants
US9278019B2 (en) 2009-04-03 2016-03-08 Metamodix, Inc Anchors and methods for intestinal bypass sleeves
US8784798B2 (en) * 2009-05-11 2014-07-22 Nestec S.A. Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
EP2459203B1 (en) * 2009-07-30 2018-10-31 DuPont Nutrition Biosciences ApS Lactic acid bacteria and bifidobacteria for treating endotoxemia
EP2691089A1 (en) * 2011-03-31 2014-02-05 Nestec S.A. Nutritional compositions for increasing arginine levels and methods of using same
KR101869498B1 (ko) * 2011-04-08 2018-06-22 시에이치알. 한센 에이/에스 시너지적 항균 효과
EP2717890B1 (de) * 2011-06-08 2016-08-10 OrganoBalance GmbH Sprühgetrocknete lactobacillus stämme / zellen und deren verwendung gegen helicobacter pylori
CN102835657B (zh) * 2011-06-20 2014-08-20 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
IN2014DN07752A (https=) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
JP6203816B2 (ja) 2012-03-29 2017-09-27 セラバイオーム，エルエルシー 回腸及び虫垂に対して活性の胃腸部位特異的経口ワクチン接種製剤
WO2013153070A1 (en) 2012-04-09 2013-10-17 Chr. Hansen A/S Bioprotection using lactobacillus paracasei strains
CN104284975B (zh) * 2012-04-09 2016-08-24 科.汉森有限公司 应用鼠李糖乳杆菌菌株的生物保护
EP2945566A4 (en) 2013-01-15 2016-10-26 Metamodix Inc SYSTEM AND METHOD FOR MODIFYING MICROBIAL INTESTINAL FLORA
AU2014239883B2 (en) 2013-03-14 2019-01-17 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
RU2565444C2 (ru) * 2013-11-28 2015-10-20 Федеральное государственное бюджетное учреждение науки Институт клеточного и внутриклеточного симбиоза Уральского отделения Российской академии наук Способ профилактики инфекционно-воспалительных осложнений у женщин с субмукозной миомой матки после гистерорезектоскопии
KR101445243B1 (ko) * 2014-03-28 2014-09-29 서울대학교산학협력단 장내 세균의 군집과 기능의 변화를 이용한 대사성 및 염증성 질환의 조기진단
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
US9622897B1 (en) 2016-03-03 2017-04-18 Metamodix, Inc. Pyloric anchors and methods for intestinal bypass sleeves
WO2017201424A1 (en) 2016-05-19 2017-11-23 Metamodix, Inc. Pyloric anchor retrieval tools and methods
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
WO2018112194A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
CA3106315A1 (en) 2018-07-19 2020-01-23 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
TWI718402B (zh) * 2018-08-16 2021-02-11 葡萄王生技股份有限公司 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途
TWI784194B (zh) * 2019-09-04 2022-11-21 台達電子工業股份有限公司 抑制具萬古黴素抗藥性腸球菌之益生菌組合與其用途
CN112438995A (zh) 2019-09-04 2021-03-05 台达电子工业股份有限公司 抑制具万古霉素抗药性肠球菌的益生菌及其组合与其用途
US20220193156A1 (en) * 2020-12-23 2022-06-23 Thi Tuyet Mai Ta Preoperative compositions and methods of preparation thereof
US12377123B2 (en) * 2020-12-23 2025-08-05 Preoperative Nutrition Preoperative compositions and methods of preparation thereof
CN113559131A (zh) * 2021-07-23 2021-10-29 科为博(江苏)生物科技研究院有限公司 一种用于改善肠胃的益生菌粉

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007393A1 (en) * 1997-08-05 1999-02-18 Rodica Teodorescu Pharmaceutical product comprising bacterial strains for the colon therapy
EP0861905B1 (en) * 1997-02-27 2004-11-24 Proge Farm S.r.l. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
US20050123527A1 (en) * 2003-10-02 2005-06-09 Conte Anthony E. Dried biotherapeutic composition, uses, and device and methods for administration thereof
WO2006046871A2 (en) * 2004-10-29 2006-05-04 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0768375B2 (fr) * 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Bactérie lactique
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
DE69707413T3 (de) * 1997-01-09 2009-07-02 Société des Produits Nestlé S.A. Probiotik enthaltendes Getreideprodukt
ES2168785T5 (es) 1997-07-05 2009-04-16 Societe Des Produits Nestle S.A. Absorcion de minerales por las celulas intestinales.
MXPA02009342A (es) * 2000-03-24 2003-09-22 Nestle Sa Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
AU5625001A (en) * 2000-04-18 2001-10-30 Societe Des Produits Nestle S.A. Nutritional modules
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US20030092163A1 (en) 2001-07-26 2003-05-15 Collins John Kevin Probiotic bifidobacterium strains
SI1565547T2 (sl) * 2002-06-28 2013-02-28 Biosearch S.A. Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
PL1638416T3 (pl) * 2003-06-23 2013-09-30 Nestec Sa Zastosowanie żywnościowego preparatu do optymalizowania działania bariery jelitowej
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
RU2293568C1 (ru) * 2006-01-10 2007-02-20 Федеральное государственное учреждение Российский центр функциональной хирургической гастроэнтерологии Федерального агентства по здравоохранению и социальному развитию (ФГУ "РЦФХГ Росздрава") Способ периоперационной коррекции дисбиоза толстой кишки у больных колоректальным раком
ES2578261T3 (es) * 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861905B1 (en) * 1997-02-27 2004-11-24 Proge Farm S.r.l. Novel lactobacilli strains useful in the treatment of disorders of the gastrointestinal system
WO1999007393A1 (en) * 1997-08-05 1999-02-18 Rodica Teodorescu Pharmaceutical product comprising bacterial strains for the colon therapy
US20050123527A1 (en) * 2003-10-02 2005-06-09 Conte Anthony E. Dried biotherapeutic composition, uses, and device and methods for administration thereof
WO2006046871A2 (en) * 2004-10-29 2006-05-04 N.V. Nutricia Peri-operative composition comprising lactobacillus rhamnosus

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BESSELINK, M.G.H. et al., Digestive Surgery, 2005, vol. 22, no. 4, pages 234-244 (X) *
RAYES N. et al., Transplantation, 2002, vol. 74, no. 1, pages 123-128 (X) *
SEEHOFER, D. et al., Journal of Surgical Research, 2004, vol. 117, no. 2, pages 262-271 (X) *

Also Published As

Publication number Publication date
CN103623010A (zh) 2014-03-12
BRPI0811180A2 (pt) 2014-10-21
MX2009012255A (es) 2009-11-25
TW200902040A (en) 2009-01-16
US20100135971A1 (en) 2010-06-03
DK1992351T3 (en) 2016-06-06
ES2578261T3 (es) 2016-07-22
JP5497634B2 (ja) 2014-05-21
CA2686976C (en) 2015-02-17
EP2146729A1 (en) 2010-01-27
EP1992351A1 (en) 2008-11-19
RU2009147036A (ru) 2011-06-27
WO2008141989A1 (en) 2008-11-27
CL2008001446A1 (es) 2009-10-02
US8529887B2 (en) 2013-09-10
JP6285108B2 (ja) 2018-02-28
AU2008253040A1 (en) 2008-11-27
CA2686976A1 (en) 2008-11-27
US20130344044A1 (en) 2013-12-26
EP1992351B1 (en) 2016-05-11
US9616094B2 (en) 2017-04-11
CN101678054A (zh) 2010-03-24
JP2013216658A (ja) 2013-10-24
RU2470652C2 (ru) 2012-12-27
JP2010527343A (ja) 2010-08-12
ZA200909002B (en) 2011-02-23

Similar Documents

Publication Publication Date Title
AU2008253040B2 (en) Probiotics in a pre- and/or post surgical environment
US12357647B2 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
RU2456008C2 (ru) Синбиотик для улучшения кишечной микробиоты
TWI494114B (zh) 鼠李醣乳酸桿菌gg(lgg)於治療、預防或減輕全身性發炎之用途
RU2543815C2 (ru) Питательные композиции, содержащие лактоферрин и пробиотики, и наборы из их частей
AU2007216461B2 (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
BRPI0814934B1 (pt) USO DE Lactobacillus rhamnosus CGMCC 1.3724 NO CONTROLE DE PESO
AU2004277417A1 (en) Compositions and methods for augmenting kidney function
PT2315595E (pt) Probióticos para aumentar a secreção de iga em lactentes nascidos por cesariana
Manigandan et al. Probiotics, prebiotics and synbiotics-a review
JP7296454B2 (ja) 炎症関連胃腸障害の処置のためのプロバイオティクスの組み合わせ
EP1738761A1 (en) Preventive and/or remedy for inflammatory bowel diseases
CN104780788A (zh) 多糖用于护理的婴儿和/或婴儿的肠道健康的用途
KR20070122480A (ko) 조제유-수유 유아에서의 전신성 염증의 치료, 예방 또는감소를 위한 락토바실루스 람노수스 ｇｇ의 용도
Singh et al. Probiotics, prebiotics, and synbiotics: a potential source for a healthy gut
EP2628394A1 (en) Probiotic functional food suitable for immunocompromised individuals undergoing treatment such as chemotherapy and/or radiotherapy
WO2025099321A1 (en) Compositions comprising human milk oligosaccharides and inactivated cells of a microorganism
Theodorou Department of Microbiology, Nutrition and Dietetics
HK1104455A (en) Preventive and/or remedy for inflammatory bowel diseases

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SOCIETE DES PRODUITS NESTLE S.A.

Free format text: FORMER OWNER(S): NESTEC S.A.